CRISPR Therapeutics AG (NASDAQ:CRSP)

64.66
Delayed Data
As of May 26
 +0.81 / +1.27%
Today’s Change
38.94
Today|||52-Week Range
86.95
+59.07%
Year-to-Date

Stock Price Forecast

The 26 analysts offering 12-month price forecasts for CRISPR Therapeutics AG have a median target of 71.00, with a high estimate of 220.00 and a low estimate of 42.00. The median estimate represents a +9.81% increase from the last price of 64.66.

Analyst Recommendations

The current consensus among 30 polled investment analysts is to Buy stock in CRISPR Therapeutics AG. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$2.13
Sales
$1.9M
Reporting Date
Aug 08

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -217.87%
 
 
 
 
 
 
Growthannually 26.34%
 
 
 
 
 
 

Sales

Growthquarterly -98.09%
 
 
 
 
 
 
Growthannually 16,554.51%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.